Fig. 8: Points of connection serve as an effective strategy for linker optimization in early-phase drug discovery efforts.

To best optimize for compound binding, flexibility and fragment binding mode can be altered through alternative points of connection between the linker and fragment. Subsequent optimization of linker-enabled interactions as well as structure-guided optimization for potency and medicinal chemistry properties would follow using more conventional lead optimization strategies.